IDO1 and neoplasm: Consistently, our findings indicated that an upregulation of L-kyn in EVs released from IDO1 high tumor cells associated with tryptophan metabolic reprogramming could further result in high levels of L-kyn in EVs derived from tumor tissues and plasma with OC patients.